Literature DB >> 28494235

ADE-ing and Abetting Zika.

Jinsheng Wen1, Sujan Shresta2.   

Abstract

Although dengue virus (DENV) antibodies can neutralize or enhance Zika virus (ZIKV) infection in vitro, their contribution to ZIKV infection in vivo remains unclear. In a recent issue of Science, Bardina et al. (2017) explore the protective versus pathogenic roles of DENV-immune antibodies in ZIKV infection using a mouse model.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28494235      PMCID： PMC5808914          DOI： 10.1016/j.chom.2017.04.006

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN： 1931-3128            Impact factor:   21.023


  10 in total

1.  Mapping and Role of the CD8+ T Cell Response During Primary Zika Virus Infection in Mice.

Authors:  Annie Elong Ngono; Edward A Vizcarra; William W Tang; Nicholas Sheets; Yunichel Joo; Kenneth Kim; Matthew J Gorman; Michael S Diamond; Sujan Shresta
Journal:  Cell Host Microbe       Date:  2017-01-11       Impact factor: 21.023

Review 2.  Dengue.

Authors:  Scott B Halstead
Journal:  Lancet       Date:  2007-11-10       Impact factor: 79.321

3.  Modified mRNA Vaccines Protect against Zika Virus Infection.

Authors:  Justin M Richner; Sunny Himansu; Kimberly A Dowd; Scott L Butler; Vanessa Salazar; Julie M Fox; Justin G Julander; William W Tang; Sujan Shresta; Theodore C Pierson; Giuseppe Ciaramella; Michael S Diamond
Journal:  Cell       Date:  2017-03-23       Impact factor: 41.582

4.  Immunogenic cross-talk between dengue and Zika viruses.

Authors:  Stephen C Harrison
Journal:  Nat Immunol       Date:  2016-08-19       Impact factor: 25.606

5.  Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity.

Authors:  Susana V Bardina; Paul Bunduc; Shashank Tripathi; James Duehr; Justin J Frere; Julia A Brown; Raffael Nachbagauer; Gregory A Foster; David Krysztof; Domenico Tortorella; Susan L Stramer; Adolfo García-Sastre; Florian Krammer; Jean K Lim
Journal:  Science       Date:  2017-03-30       Impact factor: 47.728

6.  Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease.

Authors:  Raphaël M Zellweger; Tyler R Prestwood; Sujan Shresta
Journal:  Cell Host Microbe       Date:  2010-02-18       Impact factor: 21.023

7.  Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification.

Authors:  Scott J Balsitis; Katherine L Williams; Ruben Lachica; Diana Flores; Jennifer L Kyle; Erin Mehlhop; Syd Johnson; Michael S Diamond; P Robert Beatty; Eva Harris
Journal:  PLoS Pathog       Date:  2010-02-12       Impact factor: 6.823

8.  Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8+ T cells.

Authors:  Jinsheng Wen; William Weihao Tang; Nicholas Sheets; Julia Ellison; Alessandro Sette; Kenneth Kim; Sujan Shresta
Journal:  Nat Microbiol       Date:  2017-03-13       Impact factor: 17.745

9.  The global distribution and burden of dengue.

Authors:  Samir Bhatt; Peter W Gething; Oliver J Brady; Jane P Messina; Andrew W Farlow; Catherine L Moyes; John M Drake; John S Brownstein; Anne G Hoen; Osman Sankoh; Monica F Myers; Dylan B George; Thomas Jaenisch; G R William Wint; Cameron P Simmons; Thomas W Scott; Jeremy J Farrar; Simon I Hay
Journal:  Nature       Date:  2013-04-07       Impact factor: 49.962

10.  Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus.

Authors:  Wanwisa Dejnirattisai; Piyada Supasa; Wiyada Wongwiwat; Alexander Rouvinski; Giovanna Barba-Spaeth; Thaneeya Duangchinda; Anavaj Sakuntabhai; Van-Mai Cao-Lormeau; Prida Malasit; Felix A Rey; Juthathip Mongkolsapaya; Gavin R Screaton
Journal:  Nat Immunol       Date:  2016-06-23       Impact factor: 25.606
  10 in total
  1 in total

1.  Association of past dengue fever epidemics with the risk of Zika microcephaly at the population level in Brazil.

Authors:  Marilia Sá Carvalho; Laís Picinini Freitas; Oswaldo Gonçalves Cruz; Patrícia Brasil; Leonardo Soares Bastos
Journal:  Sci Rep       Date:  2020-02-04       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.